Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:12 AM
Ignite Modification Date:
2025-12-25 @ 4:12 AM
NCT ID:
NCT05335720
Eligibility Criteria:
Inclusion Criteria:
* Patients who have donor wounds on the vertical (upper and lower) lines of the thigh through skin grafted surgery due to trauma, ulcers, burns, and incisional surgical defects.
* The size of the donor follows the standard and the distance between the two skin transplants is at least 2 cm.
* Patients who are expected to be able to successfully complete or benefit from this examination are based on appropriate medical assessment.
* Patients is willing to be treated 7 days as inpatient and treated as outpatient for maximum 7 days with homecare nurse visit.
* Patients is willing to stay near the hospital and visit the hospital after the donor site wound is declared healed by doctor.
* Patients who decided and agreed in writing to enroll in this study at their own will.
* Patients aged 18 and up
Exclusion Criteria:
* Patients with different skin donor site can influence the results of the study.
* Patients who have other diseases that can interfere with wound healing such as immunosuppressive, metabolic collagen, peripheral vascular obstructive disease (PAOD), systemic vasculitis, and others.
* Patients have the talent for keloid formation.
* Patients have uncontrolled diabetes and diabetes with complications.
* Patients with liver disease, kidney disease, and other serious diseases that can affect this study.
* Patients who are deemed difficult to carry out the study by the investigators.
* Women who are pregnant, lactation or not using reliable methods of contraception and who do not consent to continue contraception for the duration of the trial.
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT05335720
Study Brief:
Protocol Section:
NCT05335720